IRB Barcelona spin-off Gate2Brain receives EMA Orphan Drug Designation for groundbreaking pediatric cancer treatment
November 19, 2024
IRB Barcelona spin-off Gate2Brain receives EMA Orphan Drug Designation for groundbreaking pediatric cancer treatment
Gate2Brain, a pioneering technology platform focused on enhancing drug delivery to the brain, has achieved…